Literature DB >> 11912364

Glaucoma patients' assessment of their visual function and quality of life.

Henry D Jampel1, Arthur Schwartz, Irvin Pollack, Donald Abrams, Howard Weiss, Rhonda Miller.   

Abstract

PURPOSE: To determine how glaucoma and glaucoma suspect patients' rating of their vision correlates with Esterman binocular visual field testing and other visual function tests.
METHODS: One hundred ninety-one glaucoma patients and 46 glaucoma suspect patients underwent binocular visual field testing and evaluated their vision using the linear rating scale and time-tradeoff utility tests, the National Eye Institute Visual Functional Questionnaire (NEI VFQ-25), and the Short Form 36 (SF-36) quality-of-life instruments.
RESULTS: The mean Esterman score was 88.2 +/- 17.4 for the glaucoma subjects and 95.2 + 6.9 for glaucoma suspect subjects (maximum score 100). On a scale from 0 (blind) to 100 (ideal), the mean rating of vision for glaucoma patients and glaucoma suspect patients was 74.8 +/- 17.3 and 78.9 +/- 18.5, respectively. The Esterman test correlated moderately with the overall NEI VFQ-25 score (partial correlation coefficient (PCC) = 0.32, P = 0.001), but only weakly with the linear rating scale (PCC = 0.17, P = 0.02), and the time-tradeoff (PCC = 0.14, P = 0.06).
CONCLUSION: Utility values that glaucoma and glaucoma suspect patients assign to their vision do not correlate well with Esterman results. A challenge for the future is the design of clinical tests of vision that better correlate with patient perceptions.

Entities:  

Mesh:

Year:  2002        PMID: 11912364     DOI: 10.1097/00061198-200204000-00012

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  43 in total

1.  Effect of patient's life expectancy on the cost-effectiveness of treatment for ocular hypertension.

Authors:  Steven M Kymes; Michael R Plotzke; Michael A Kass; Michael V Boland; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2010-05

2.  Psychometric performance of the national eye institute 25-item visual function questionnaire: in Turkish diabetic retinopathy patients.

Authors:  Akinci Fevzi; Yildirim Aysegul
Journal:  Patient       Date:  2008-04-01       Impact factor: 3.883

3.  Vision-related quality of life in first stroke patients with homonymous visual field defects.

Authors:  Carolin Gall; Gabriele H Franke; Bernhard A Sabel
Journal:  Health Qual Life Outcomes       Date:  2010-03-26       Impact factor: 3.186

4.  Development of an Arabic version of the National Eye Institute Visual Function Questionnaire as a tool to study eye diseases patients in Egypt.

Authors:  Nizar Saleh Abdelfattah; Mohamed Amgad; Ahmed A Salama; Marina E Israel; Ghada A Elhawary; Ahmed E Radwan; Mohamed M Elgayar; Tamer M El Nakhal; Islam T Elkhateb; Heba A Hashem; Doha K Embaby; Amira A Elabd; Reem K Elwy; Magdi S Yacoub; Hamdy Salem; Mohamed Abdel-Baqy; Ahmad Kassem
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

5.  What Is the Amount of Visual Field Loss Associated With Disability in Glaucoma?

Authors:  Alessandro A Jammal; Nara G Ogata; Fábio B Daga; Ricardo Y Abe; Vital P Costa; Felipe A Medeiros
Journal:  Am J Ophthalmol       Date:  2018-09-17       Impact factor: 5.258

6.  Fast Visual Field Progression Is Associated with Depressive Symptoms in Patients with Glaucoma.

Authors:  Alberto Diniz-Filho; Ricardo Y Abe; Hyong Jin Cho; Saif Baig; Carolina P B Gracitelli; Felipe A Medeiros
Journal:  Ophthalmology       Date:  2016-02-23       Impact factor: 12.079

7.  The utility of strabismus in adults.

Authors:  George R Beauchamp; Joost Felius; David R Stager; Cynthia L Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  2005

8.  Five-year forecasts of the Visual Field Index (VFI) with binocular and monocular visual fields.

Authors:  Ryo Asaoka; Richard A Russell; Rizwan Malik; David F Garway-Heath; David P Crabb
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-07       Impact factor: 3.117

9.  [Health-economic aspects of glaucoma screening].

Authors:  C Hirneiss; A Niedermaier; M Kernt; A Kampik; A S Neubauer
Journal:  Ophthalmologe       Date:  2010-02       Impact factor: 1.059

10.  The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration.

Authors:  Keith Evans; Simon K Law; John Walt; Patricia Buchholz; Jan Hansen
Journal:  Clin Ophthalmol       Date:  2009-08-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.